Literature DB >> 16242433

Carotid-subclavian artery index: new echocardiographic index to detect coarctation in neonates and infants.

Ali Dodge-Khatami1, Stephanie Ott, Stefano Di Bernardo, Felix Berger.   

Abstract

BACKGROUND: In neonates and young infants (less than 3 months), coarctation may be missed or underestimated by echocardiography, especially with a patent ductus arteriosus or severe concurrent illness. A reliable noninvasive screening tool for coarctation would be useful for these patients.
METHODS: From 1997 to 2003, echocardiographic evaluation was performed in 63 consecutive patients with coarctation (47 neonates and 16 infants) as well as in 23 controls (16 neonates and 7 infants). End-systolic measurements were obtained from 12 different sites of the aortic arch.
RESULTS: In patients, the diameters of the ascending and descending aorta were comparable to controls, but the dimensions of the transverse arch were significantly smaller. The distances between the origins of the great vessels were longer in patients with coarctation than in controls. The ratio of the aortic arch diameter at the left subclavian artery, to the distance between the left carotid artery and the left subclavian artery, which we propose as the carotid-subclavian artery index, was significantly smaller in patients with coarctation. A cut-off point at 1.5 showed a sensitivity of 97.7% and 94.7%, and a specificity of 92.3% and 100%, for neonates and young infants, respectively. The positive predictive value to have coarctation was 97.7% and 100%, for neonates and infants, respectively.
CONCLUSIONS: The carotid-subclavian artery index is a simply obtainable noninvasive screening parameter, showing high sensitivity and specificity for coarctation, and may be useful in unstable patients or in those with a patent ductus arteriosus in which coarctation may be overlooked.

Entities:  

Mesh:

Year:  2005        PMID: 16242433     DOI: 10.1016/j.athoracsur.2005.04.041

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Right Ventricular Enlargement In Utero: Is It Coarctation?

Authors:  Shanthi Sivanandam; Jessica Nyholm; Andrew Wey; John L Bass
Journal:  Pediatr Cardiol       Date:  2015-04-08       Impact factor: 1.655

2.  A clinical prediction model to estimate the risk for coarctation of the aorta in the presence of a patent ductus arteriosus.

Authors:  Jonathan H Soslow; Ann Kavanaugh-McHugh; Li Wang; Daniel L Saurers; Neeru Kaushik; Stacy A S Killen; David A Parra
Journal:  J Am Soc Echocardiogr       Date:  2013-09-23       Impact factor: 5.251

3.  Fetal Echocardiographic Dimension Indices: Important Predictors of Postnatal Coarctation.

Authors:  Katrin Fricke; Petru Liuba; Constance G Weismann
Journal:  Pediatr Cardiol       Date:  2020-12-23       Impact factor: 1.655

4.  Tunable Blood Shunt for Neonates With Complex Congenital Heart Defects.

Authors:  Ellen Garven; Christopher B Rodell; Kristen Shema; Krianthan Govender; Samantha E Cassel; Bryan Ferrick; Gabriella Kupsho; Ethan Kung; Kara L Spiller; Randy Stevens; Amy L Throckmorton
Journal:  Front Bioeng Biotechnol       Date:  2022-01-13

5.  Doppler echocardiographic indices in aortic coarctation: a comparison of profiles before and after stenting.

Authors:  Shokoufeh Hajsadeghi; Seyed-Mohammad Fereshtehnejad; Mahshid Ojaghi; Hossein Ali Bassiri; Mohammad Reza Keramati; Mitra Chitsazan; Saeid Gholami
Journal:  Cardiovasc J Afr       Date:  2012-10       Impact factor: 1.167

6.  Analysis of 3-Dimensional Arch Anatomy, Vascular Flow, and Postnatal Outcome in Cases of Suspected Coarctation of the Aorta Using Fetal Cardiac Magnetic Resonance Imaging.

Authors:  David F A Lloyd; Milou P M van Poppel; Kuberan Pushparajah; Trisha V Vigneswaran; Vita Zidere; Johannes Steinweg; Joshua F P van Amerom; Thomas A Roberts; Alexander Schulz; Marietta Charakida; Owen Miller; Gurleen Sharland; Mary Rutherford; Joseph V Hajnal; John M Simpson; Reza Razavi
Journal:  Circ Cardiovasc Imaging       Date:  2021-06-30       Impact factor: 7.792

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.